newsfilter
← Latest News
GlobeNewswire·

Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference

  • Vor Bio management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London, United Kingdom.
  • The presentation is scheduled for Tuesday, November 17, 2026, from 10:30 am to 10:55 am GMT.
  • A live webcast of the presentation will be accessible on the Investors section of Vor's website at ir.vorbio.com.
  • A replay of the webcast will be available on the website for approximately 30 days following the event.
  • Vor Bio is a clinical-stage biotechnology company focused on advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development for autoimmune diseases.
Company
Vor Biopharma
Keywords
Nasdaq:VOR, Vor Biopharma